ASLN - Why ASLAN Pharmaceuticals (ASLN) Shares Are Down 40% | Benzinga
ASLAN Pharmaceuticals Ltd (NASDAQ:ASLN) shares are trading lower by 38.7% to $0.68 during Wednesday’s session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation.
The company says this decision was made following a thorough review of ASLAN SG’s financial situation and strategic options. As a result, all employees of ASLAN SG and its subsidiary in the USA have ...
ASLN) Shares Are Down 40%>Full story available on Benzinga.com